StableEyes With Active Neurofeedback
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-70
SponsorJohns Hopkins University
About this trial
The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
Willing to adhere to the SWAN and/or vestibular rehabilitation regimen
Disqualifiers
Current use of anti-nausea medication
Presence of cervical spine pathology that limits head motion to < 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
Legal blindness (20/200 or worse visual acuity)
Trial design
Treatments tested in this trial
- Traditional Therapy
- SWAN
Treatment groups
48 Participants
are divided into 4 treatment groupsSponsors and collaborators
Johns Hopkins University
Lead sponsor
National Aeronautics and Space Administration (NASA)
Collaborator
Source ClinicalTrials.gov